GlaxoSmithkline Consumer Healthcare announced a substantial rise in standalone net profit for the quarter ended December 2015. During the quarter, the profit of the company rose 36.76% to Rs 1,318.50 million from Rs 964.10 million in the same quarter last year.
Revenues for the quarter rose marginally 1.68% to Rs 10,294.70 million, compared with Rs 10,125 million for the prior year period.
Operating margin for the quarter stood at 14.18 percent as compared to 9.16 percent for the previous year period. Operating Income for the quarter was Rs 1,459.50 million, compared with Rs 927.6 million in the previous year period.
Earnings per share for the quarter stood at Rs 31.35, registering 36.78% growth over previous year period.
| Quarterly Results - Standalone (Rs in mn) |
| As at | Dec - 15 | Dec - 14 | %Change |
| Revenues | 10,294.70 | 10,124.80 | 1.68 |
| Net Profit | 1,318.50 | 964.10 | 36.76 |
| Diluted EPS | 31.35 | 22.92 | 36.78 |
Shares of the company gained Rs 69.5, or 1.21%, to settle at Rs 5,820.30. The total volume of shares traded was 141 at the BSE (Monday).
